NM_021098.3:c.5253C>T

Variant names:

Variant summary

Our verdict is Benign. The variant received -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BS1BS2

The NM_021098.3(CACNA1H):c.5253C>T(p.Asn1751Asn) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00209 in 1,602,734 control chromosomes in the GnomAD database, including 10 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0017 ( 1 hom., cov: 34)

Exomes 𝑓: 0.0021 ( 9 hom. )

Consequence

CACNA1H
NM_021098.3 synonymous

Scores

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: 2.49

Publications

3 publications found

Variant links:

Genes affected

CACNA1H (HGNC:1395): (calcium voltage-gated channel subunit alpha1 H) This gene encodes a T-type member of the alpha-1 subunit family, a protein in the voltage-dependent calcium channel complex. Calcium channels mediate the influx of calcium ions into the cell upon membrane polarization and consist of a complex of alpha-1, alpha-2/delta, beta, and gamma subunits in a 1:1:1:1 ratio. The alpha-1 subunit has 24 transmembrane segments and forms the pore through which ions pass into the cell. There are multiple isoforms of each of the proteins in the complex, either encoded by different genes or the result of alternative splicing of transcripts. Alternate transcriptional splice variants, encoding different isoforms, have been characterized for the gene described here. Studies suggest certain mutations in this gene lead to childhood absence epilepsy (CAE). [provided by RefSeq, Jul 2008]

CACNA1H Gene-Disease associations (from GenCC):

hyperaldosteronism, familial, type IV
Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
childhood absence epilepsy
Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
epilepsy, childhood absence, susceptibility to, 6
Inheritance: AD Classification: LIMITED Submitted by: G2P, Labcorp Genetics (formerly Invitae)

CACNA1H links:

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -19 ACMG points.

BP4

Computational evidence support a benign effect (BayesDel_noAF=-0.44).

BP6

Variant 16-1216940-C-T is Benign according to our data. Variant chr16-1216940-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 460141.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-1216940-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 460141.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-1216940-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 460141.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-1216940-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 460141.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-1216940-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 460141.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-1216940-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 460141.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-1216940-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 460141.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-1216940-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 460141.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-1216940-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 460141.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-1216940-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 460141.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-1216940-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 460141.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-1216940-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 460141.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-1216940-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 460141.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-1216940-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 460141.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-1216940-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 460141.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-1216940-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 460141.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-1216940-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 460141.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-1216940-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 460141.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-1216940-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 460141.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-1216940-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 460141.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-1216940-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 460141.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-1216940-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 460141.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.

BP7

Synonymous conserved (PhyloP=2.49 with no splicing effect.

BS1

Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00174 (265/152316) while in subpopulation NFE AF = 0.00316 (215/68010). AF 95% confidence interval is 0.00281. There are 1 homozygotes in GnomAd4. There are 123 alleles in the male GnomAd4 subpopulation. Median coverage is 34. This position passed quality control check.

BS2

High AC in GnomAd4 at 265 AD gene.

Transcripts

RefSeq

Gene	Transcript	HGVSc	HGVSp	Effect	Exon rank	MANE	Protein	UniProt
CACNA1H	NM_021098.3 link	c.5253C>T	p.Asn1751Asn	synonymous_variant	Exon 31 of 35	ENST00000348261.11	NP_066921.2	O95180-1B3KQH9

Ensembl

Gene	Transcript	HGVSc	HGVSp	Effect	Exon rank	TSL	MANE	Protein	UniProt
CACNA1H	ENST00000348261.11 link	c.5253C>T	p.Asn1751Asn	synonymous_variant	Exon 31 of 35	1	NM_021098.3	ENSP00000334198.7	O95180-1
CACNA1H	ENST00000569107.6 link	c.5268C>T	p.Asn1756Asn	synonymous_variant	Exon 30 of 34	1		ENSP00000454990.2	H3BNT0
CACNA1H	ENST00000711493.1 link	c.5271C>T	p.Asn1757Asn	synonymous_variant	Exon 30 of 34			ENSP00000518778.1
CACNA1H	ENST00000565831.7 link	c.5235C>T	p.Asn1745Asn	synonymous_variant	Exon 30 of 34	1		ENSP00000455840.1	O95180-2
CACNA1H	ENST00000711450.1 link	c.5268C>T	p.Asn1756Asn	synonymous_variant	Exon 31 of 35			ENSP00000518762.1
CACNA1H	ENST00000564231.6 link	c.5253C>T	p.Asn1751Asn	synonymous_variant	Exon 31 of 35	1		ENSP00000457555.2	H3BUA8
CACNA1H	ENST00000638323.1 link	c.5214C>T	p.Asn1738Asn	synonymous_variant	Exon 31 of 35	5		ENSP00000492267.1	A0A1W2PR14
CACNA1H	ENST00000562079.6 link	c.5235C>T	p.Asn1745Asn	synonymous_variant	Exon 30 of 34	1		ENSP00000454581.2	H3BMW6
CACNA1H	ENST00000711438.1 link	c.5196C>T	p.Asn1732Asn	synonymous_variant	Exon 30 of 34			ENSP00000518754.1
CACNA1H	ENST00000711482.1 link	c.5253C>T	p.Asn1751Asn	synonymous_variant	Exon 31 of 36			ENSP00000518771.1
CACNA1H	ENST00000711485.1 link	c.5235C>T	p.Asn1745Asn	synonymous_variant	Exon 30 of 35			ENSP00000518774.1
CACNA1H	ENST00000711455.1 link	c.5253C>T	p.Asn1751Asn	synonymous_variant	Exon 31 of 36			ENSP00000518768.1
CACNA1H	ENST00000711483.1 link	c.5253C>T	p.Asn1751Asn	synonymous_variant	Exon 31 of 35			ENSP00000518772.1
CACNA1H	ENST00000711456.1 link	c.5253C>T	p.Asn1751Asn	synonymous_variant	Exon 31 of 34			ENSP00000518769.1
CACNA1H	ENST00000621827.2 link	n.5253C>T		non_coding_transcript_exon_variant	Exon 31 of 37	6		ENSP00000518766.1
CACNA1H	ENST00000637236.3 link	n.*1205C>T		non_coding_transcript_exon_variant	Exon 30 of 34	5		ENSP00000492650.2	A0A1W2PS38
CACNA1H	ENST00000639478.1 link	n.*334C>T		non_coding_transcript_exon_variant	Exon 31 of 35	5		ENSP00000491945.1	A0A1W2PQW2
CACNA1H	ENST00000640028.1 link	n.*3104C>T		non_coding_transcript_exon_variant	Exon 31 of 35	5		ENSP00000491488.1	A0A1W2PQ19
CACNA1H	ENST00000711442.1 link	n.*4697C>T		non_coding_transcript_exon_variant	Exon 29 of 34			ENSP00000518758.1
CACNA1H	ENST00000711448.1 link	n.*112C>T		non_coding_transcript_exon_variant	Exon 31 of 36			ENSP00000518760.1
CACNA1H	ENST00000711449.1 link	n.*112C>T		non_coding_transcript_exon_variant	Exon 31 of 35			ENSP00000518761.1
CACNA1H	ENST00000711451.1 link	n.*254C>T		non_coding_transcript_exon_variant	Exon 31 of 36			ENSP00000518763.1
CACNA1H	ENST00000711452.1 link	n.5253C>T		non_coding_transcript_exon_variant	Exon 31 of 36			ENSP00000518764.1
CACNA1H	ENST00000711453.1 link	n.5253C>T		non_coding_transcript_exon_variant	Exon 31 of 36			ENSP00000518765.1
CACNA1H	ENST00000711484.1 link	n.5235C>T		non_coding_transcript_exon_variant	Exon 30 of 35			ENSP00000518773.1
CACNA1H	ENST00000711486.1 link	n.5253C>T		non_coding_transcript_exon_variant	Exon 31 of 37			ENSP00000518775.1
CACNA1H	ENST00000711487.1 link	n.5253C>T		non_coding_transcript_exon_variant	Exon 31 of 36			ENSP00000518776.1
CACNA1H	ENST00000711488.1 link	n.*254C>T		non_coding_transcript_exon_variant	Exon 30 of 35			ENSP00000518777.1
CACNA1H	ENST00000637236.3 link	n.*1205C>T		3_prime_UTR_variant	Exon 30 of 34	5		ENSP00000492650.2	A0A1W2PS38
CACNA1H	ENST00000639478.1 link	n.*334C>T		3_prime_UTR_variant	Exon 31 of 35	5		ENSP00000491945.1	A0A1W2PQW2
CACNA1H	ENST00000640028.1 link	n.*3104C>T		3_prime_UTR_variant	Exon 31 of 35	5		ENSP00000491488.1	A0A1W2PQ19
CACNA1H	ENST00000711442.1 link	n.*4697C>T		3_prime_UTR_variant	Exon 29 of 34			ENSP00000518758.1
CACNA1H	ENST00000711448.1 link	n.*112C>T		3_prime_UTR_variant	Exon 31 of 36			ENSP00000518760.1
CACNA1H	ENST00000711449.1 link	n.*112C>T		3_prime_UTR_variant	Exon 31 of 35			ENSP00000518761.1
CACNA1H	ENST00000711451.1 link	n.*254C>T		3_prime_UTR_variant	Exon 31 of 36			ENSP00000518763.1
CACNA1H	ENST00000711488.1 link	n.*254C>T		3_prime_UTR_variant	Exon 30 of 35			ENSP00000518777.1

Frequencies

GnomAD3 genomes

AF:

0.00174

AC:

265

AN:

152198

Hom.:

Cov.:

show subpopulations

Gnomad AFR

AF:

0.000362

Gnomad AMI

AF:

0.00

Gnomad AMR

AF:

0.000851

Gnomad ASJ

AF:

0.00

Gnomad EAS

AF:

0.00

Gnomad SAS

AF:

0.00207

Gnomad FIN

AF:

0.000282

Gnomad MID

AF:

0.00633

Gnomad NFE

AF:

0.00316

Gnomad OTH

AF:

0.00334

GnomAD2 exomes

AF:

0.00170

AC:

384

AN:

226014

AF XY:

0.00178

show subpopulations

Gnomad AFR exome

AF:

0.000296

Gnomad AMR exome

AF:

0.000868

Gnomad ASJ exome

AF:

0.000731

Gnomad EAS exome

AF:

0.00

Gnomad FIN exome

AF:

0.000247

Gnomad NFE exome

AF:

0.00260

Gnomad OTH exome

AF:

0.00354

GnomAD4 exome

AF:

0.00213

AC:

3084

AN:

1450418

Hom.:

Cov.:

AF XY:

0.00216

AC XY:

1559

AN XY:

720420

show subpopulations

African (AFR)

AF:

0.000330

AC:

AN:

33352

American (AMR)

AF:

0.000838

AC:

AN:

42964

Ashkenazi Jewish (ASJ)

AF:

0.000425

AC:

AN:

25886

East Asian (EAS)

AF:

0.00

AC:

AN:

39340

South Asian (SAS)

AF:

0.00226

AC:

190

AN:

84038

European-Finnish (FIN)

AF:

0.000344

AC:

AN:

52384

Middle Eastern (MID)

AF:

0.00382

AC:

AN:

5754

European-Non Finnish (NFE)

AF:

0.00242

AC:

2677

AN:

1106734

Other (OTH)

AF:

0.00198

AC:

119

AN:

59966

Allele Balance Distribution

Red line indicates average allele balance

Average allele balance: 0.440

Heterozygous variant carriers

155

310

464

619

774

0.00

0.20

0.40

0.60

0.80

0.95

Allele balance

Age Distribution

Exome Het

Exome Hom

Variant carriers

172

258

344

430

<30

30-35

35-40

40-45

45-50

50-55

55-60

60-65

65-70

70-75

75-80

>80

Age

GnomAD4 genome

AF:

0.00174

AC:

265

AN:

152316

Hom.:

Cov.:

AF XY:

0.00165

AC XY:

123

AN XY:

74480

show subpopulations

African (AFR)

AF:

0.000361

AC:

AN:

41578

American (AMR)

AF:

0.000849

AC:

AN:

15304

Ashkenazi Jewish (ASJ)

AF:

0.00

AC:

AN:

3472

East Asian (EAS)

AF:

0.00

AC:

AN:

5180

South Asian (SAS)

AF:

0.00207

AC:

AN:

4828

European-Finnish (FIN)

AF:

0.000282

AC:

AN:

10622

Middle Eastern (MID)

AF:

0.00680

AC:

AN:

294

European-Non Finnish (NFE)

AF:

0.00316

AC:

215

AN:

68010

Other (OTH)

AF:

0.00331

AC:

AN:

2116

Allele Balance Distribution

Red line indicates average allele balance

Average allele balance: 0.501

Heterozygous variant carriers

0.00

0.20

0.40

0.60

0.80

0.95

Allele balance

Age Distribution

Genome Het

Variant carriers

<30

30-35

35-40

40-45

45-50

50-55

55-60

60-65

65-70

70-75

75-80

>80

Age

Alfa

AF:

0.00153

Hom.:

Bravo

AF:

0.00157

Asia WGS

AF:

0.000577

AC:

AN:

3478

ClinVar

Significance: Benign/Likely benign

Submissions summary: Benign:4

Revision: criteria provided, multiple submitters, no conflicts

LINK: link

Submissions by phenotype

Epilepsy, childhood absence, susceptibility to, 6;C4310756:Hyperaldosteronism, familial, type IV

Benign:1

Oct 14, 2021

Fulgent Genetics, Fulgent Genetics

Significance:Likely benign

Review Status:criteria provided, single submitter

Collection Method:clinical testing

- -

CACNA1H-related disorder

Benign:1

Oct 11, 2019

PreventionGenetics, part of Exact Sciences

Significance:Likely benign

Review Status:no assertion criteria provided

Collection Method:clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Idiopathic generalized epilepsy;C4310756:Hyperaldosteronism, familial, type IV

Benign:1

Feb 02, 2025

Labcorp Genetics (formerly Invitae), Labcorp

Significance:Benign

Review Status:criteria provided, single submitter

Collection Method:clinical testing

- -

not provided

Benign:1

Dec 01, 2024

CeGaT Center for Human Genetics Tuebingen

Significance:Likely benign

Review Status:criteria provided, single submitter

Collection Method:clinical testing

CACNA1H: BP4, BP7 -

Computational scores

Source: dbNSFP v4.3

Name

Calibrated prediction

Score

Prediction

BayesDel_noAF

Benign

-0.44

CADD

Benign

(source)

DANN

Benign

0.82

PhyloP100

2.5

Mutation Taster

=99/1

polymorphism

(source)

Splicing

Name

Calibrated prediction

Score

Prediction

SpliceAI score (max)

0.0

Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.

Variant summary

Frequency

Consequence

Scores

Clinical Significance

Conservation

Publications

ACMG classification

Transcripts

RefSeq

Ensembl

Frequencies

Age Distribution

Age Distribution

ClinVar

Submissions by phenotype

Computational scores

Splicing

Publications

Other links and lift over